AFP , SHANGHAI
China yesterday defended its decision to overturn Pfizer's patent for Viagra in a ruling seen as a setback to protection of intellectual property rights in the country.
The US makers of the top selling erectile disfunction drug were in breach of China's intellectual property rights (IPR) law when they failed to accurately explain "technological" uses of Viagra's key ingredient, an official with the State Intellectual Property Office (SIPO) said.
"If you widen the description of the
technological uses, you could likely be violating the patent right of others," the SIPO official said on condition of anonymity.
http://www.taipeitimes.com/News/worldbiz/archives/2004/07/09/2003178299
Viagra doesn't have anything to do with 'disfunction'. It's being sold as Crack.